April 9 (Reuters) - Captor Therapeutics SA CTXP.WA :
* REPORTED ITS FY 2023 FINANCIAL RESULTS
* FY 2023 NET LOSS AT 70.6 MILLION ZLOTYS VERSUS LOSS OF
35.9
MILLION ZLOTYS YEAR AGO
* FY 2023 REVENUE FROM R&D SERVICES AT 13.2 MILLION ZLOTYS
VERSUS
9.2 MILLION ZLOTYS YEAR AGO
* FY 2023 OPERATING LOSS AT 73.0 MILLION ZLOTYS VERSUS LOSS
OF
38.4 MILLION ZLOTYS YEAR AGO
Source text for Workspace: urn:newsml:reuters.com:*:nEMbrLwhna
Further company coverage: CTXP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))